Abstract
Migraine patients who do not respond to conventional therapy, develop unacceptable side-effects, or are reluctant to take medicines resort to complementary and alternative medicines (CAM). Globally, patients have been seeking various non-conventional modes of therapy for the management of their headaches. An Ayurvedic Treatment Protocol (AyTP) comprising five Ayurvedic medicines, namely Narikel Lavan, Sootshekhar Rasa, Sitopaladi Churna, Rason Vati and Godanti Mishran along with regulated diet and lifestyle modifications such as minimum 8 h sleep, 30-60 min morning or evening walk and abstention from smoking/drinking, was tried for migraine treatment. The duration of the therapy was 90 days. Out of 406 migraine patients who were offered this AyTP, 204 patients completed 90 days of treatment. Complete disappearance of headache and associated symptoms at completion of AyTP was observed in 72 (35.2%); mild episode of headache without need of any conventional medicines in 72 (35.2%); low intensity of pain along with conventional medicines in 50 (24.5%); no improvement in seven (3.4%) and worst pain was noted in three (1.4%) patients, respectively. In 144 (70.5%) of patients marked reduction of migraine frequency and pain intensity observed may be because of the AyTP. Though the uncontrolled open-label design of this study does not allow us to draw a definite conclusion, from this observational study we can make a preliminary assessment regarding the effectiveness of this ayurvedic treatment protocol.
Highlights
Migraine is a widespread, chronic and intermittently disabling disorder characterized by recurrent headaches with or without aura.[1]
Ayurvedic Treatment Protocol (AyTP) was first carried out in Dhanwamtari Ayurvedic College and Hospital, Chandigarh from June 2002 to December 2004. In this series we report the analysis of the observational prospective clinical study of this AyTP carried on 406 migraine patients in nine major cities of south India
Though Ayurvedic therapy is popular among migraine sufferers, there are very few reports available on the efficacy and toxicity of these therapies
Summary
Chronic and intermittently disabling disorder characterized by recurrent headaches with or without aura.[1]. Some specific drugs such as Triptans and ergotamine tartrate are often expensive and not commonly used in resource-poor countries, resulting in a significant amount of pain and disability.[4] Another problem is the actual overuse of such medications which causes ‘medication overuse headache’. AyTP was first carried out in Dhanwamtari Ayurvedic College and Hospital, Chandigarh from June 2002 to December 2004 In this series we report the analysis of the observational prospective clinical study of this AyTP carried on 406 migraine patients in nine major cities of south India
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
